The first Turkish company on the list of the world’s largest pharmaceutical companies, Abdi İbrahim was founded as a small pharmaceutical laboratory in 1912. Since 2003, it has been the leading company in the Turkish pharmaceuticals markets. It serves medicine and people through its pharmaceuticals and its pioneering, innovative style, and is today a respected, rapidly growing and elite player in the Turkish pharmaceutical market. Having not been confined with domestic achievements, Abdi İbrahim has adopted “being a global actor” as one of the fundamental principles of its vision and is continuing to expand in international markets. The company achieved a volume of 250 Marketing Authorizations in international markets.